Dutch stop giving AstraZeneca vaccine to under-60s pending review

Australia investigates possible link of blood clot case to vaccine

The Medicines and Healthcare products Regulatory Agency said it had received no blood clot events following use of Pfizer-BioNTech vaccine.

Germany restricted the use of the shot to people over 60 years of age, France has limited its use to those over 55.

On Friday, the medicine regulator told the Financial Times and The Guardian that seven recipients of the AstraZeneca vaccine have died after registering the rare blood clotting events.

While investigations continue, both the TGA and the Australian Technical Advisory Group on Immunisation (ATAGI) have said no change to Australia's vaccine rollout was needed.

That's despite rising cases of rare blood clots possibly linked to the jab.

AstraZeneca Plc said the review of safety data of people vaccinated with its Covid-19 vaccine has shown no evidence of an increased risk of blood clots.

"Nevertheless, the extreme rarity of these events in the context of the many millions of vaccine doses that have been administered means that the risk-benefit decision facing people who are invited to receive Covid-19 vaccines is very straight forward: receiving the vaccine is by far the safest choice in terms of minimising individual risk of serious illness or death".

"Don't worry because we have medicine to treat allergies such as muscle pain, fever or itchiness", he said in a news conference at the Back to School Haircut Programme for schools in the Bagan Serai parliamentary constituency at the Pusat GiatMara Bagan Serai here today.

The woman, a social worker, who was vaccinated in mid-March due to her work at a centre with disabled people - did not suffer from any particular health problems, added Boittin.

"My general feeling is that given the contractual relationships that we have with a number of companies, that we have enough vaccine to fulfill all of our needs without invoking AstraZeneca,"Fauci said".

The British acknowledgment of deaths comes as several European countries have paused the use of the AstraZeneca jab over a potential link to blood clots.

United Kingdom records more AstraZeneca blot cases and seven die as a result, Argentine president tests positive and the USA vaccinates more than 1 million people.

In a statement, the government said there had been five reports of thrombosis and abnormally low platelets, which help blood clot, in women aged 25 to 65 (around 400,000 AstraZeneca injections have been given in the Netherlands, according to the same government statement).



Latest news

Ontario back into shutdown starting April 3
New modelling also shows Ontario could have up to 6,000 new cases a day by the end of April due to the new variants of the virus. Essential retail stores are capped at 50 per cent of their maximum capacity and non-essential stores are limited to 25 per cent.

Suspect in Capitol barricade attack had declining mental health, friends, family say
Capitol Police Officer William "Billy" Evans died Friday when an attacker with a knife lunged toward authorities, officials said. Biden commented on the earlier attack saying that it was a riotous mob and the participants were domestic terrorists.

United States says vaccinated people can travel, with precautions
The state travel advisory also says nonessential travelers who don't get tested should self-quarantine for 10 days after travel. CDC discourages non-essential domestic travel by those who are not fully vaccinated.

Australia investigates possible link of blood clot case to AstraZeneca vaccine
It also ordered 30 million doses of the Pfizer-BioNTech vaccine the same year. The vaccine was developed with the University of Oxford in Britain.

Rebel group says more than 12,000 displaced by Myanmar junta air strikes
About 3,000 Karen villagers have fled to neighboring Thailand in recent days, but many have returned under unclear circumstances. In another escalation, since Saturday the military has launched regular air strikes targeting the KNU in eastern Karen state.

Other news